Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10238-022-00809-0.pdf
Reference38 articles.
1. Forconi, F., Moss, P. 2015. Perturbation of the normal immune system in patients with CLL. Blood. Content Repository Only! 126:573–81.
2. Bergmann L, Fenchel K, Jahn B, Mitrou PS, Hoelzer D. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Annals of Oncology Klmver Academic Publishers. 1993;4:371–5.
3. McLaughlin P, Grillo-López AJ, Link BK, Levy R, Czuczman MS, Williams ME, et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. Proc Am Soc Clin Oncol. 2016;16:2825–33.
4. Solimando, A.G., Ribatti, D., Vacca, A., Einsele, H. 2016. Targeting B-cell non Hodgkin lymphoma: New and old tricks. Leukemia research [Internet]. Leuk Res; [cited 2022 Jan 25];42:93–104. Available from: https://pubmed.ncbi.nlm.nih.gov/26818572/
5. Maloney DG, Grillo-López AJ, Bodkin DJ, White CA, Liles TM, Royston I, et al. IDEC-C2B8 results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin’s lymphoma. J Clin Oncol. 1997;15:3266–74.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A case report of prolonged viral shedding of SARS-CoV-2 in a patient who receive ibrutinib for CLL therapy;BMC Infectious Diseases;2024-09-02
2. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment;Journal of Functional Biomaterials;2024-08-16
3. Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study;Vaccine;2024-02
4. Analysis of Humoral and Cellular Responses after Vaccination Against Sars-Cov-2 in Patients with Immune-Mediated Diseases;2024
5. COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?;Acta Haematologica;2023-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3